1. Immunoglobulin G4-related Hepatopathy after COVID-19 Vaccination.
- Author
-
Kuno M, Sawa N, Mizuno H, Oba Y, Ikuma D, Sekine A, Yamanouchi M, Hasegawa E, Suwabe T, Saito S, Kono K, Kinowaki K, Notohara K, and Ubara Y
- Subjects
- Aged, 80 and over, Female, Humans, Immunoglobulin G, COVID-19 prevention & control, COVID-19 Vaccines adverse effects, Immunoglobulin G4-Related Disease pathology, Liver Diseases etiology
- Abstract
An 84-year-old woman with IgG4-related disease presented with jaundice and liver dysfunction after coronavirus disease 2019 (COVID-19) vaccination. Serum IgG4 levels were elevated. Diagnostic imaging showed no stenotic lesions in the bile ducts. A liver biopsy was performed because of the enlarged liver. Infiltration of IgG4-positive plasma cells, which accounted for approximately 74% of total plasma cells, was found in the portal area, but there was no evidence of periportal hepatitis, and inflammatory cell infiltration into the lobular space was minimal. IgG4-related hepatopathy was diagnosed. The patient achieved spontaneous remission with no treatment and only follow-up and remains under observation at the time of writing.
- Published
- 2023
- Full Text
- View/download PDF